There was a 12% reduction in cancer diagnoses in the years following AI-supported breast cancer screening — a key test of effectiveness, researchers reported Jan. 29 in The Lancet. Researchers ...
Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs.com. The U.S. Food and Drug Administration (FDA) first approved it in 2014 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results